Quantifying the effects of antiangiogenic and chemotherapy drug combinations on drug delivery and treatment efficacy
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Quantifying the effects of antiangiogenic and chemotherapy drug combinations on drug delivery and treatment efficacy
Authors
Keywords
Cancer chemotherapy, Chemotherapeutic agents, Drug delivery, Combination chemotherapy, Angiogenesis, Liposomes, Cancer treatment, Nanoparticles
Journal
PLoS Computational Biology
Volume 13, Issue 9, Pages e1005724
Publisher
Public Library of Science (PLoS)
Online
2017-09-19
DOI
10.1371/journal.pcbi.1005724
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The intra-tumoral relationship between microcirculation, interstitial fluid pressure and liposome accumulation
- (2015) Shawn Stapleton et al. JOURNAL OF CONTROLLED RELEASE
- Spatial and temporal mapping of heterogeneity in liposome uptake and microvascular distribution in an orthotopic tumor xenograft model
- (2015) Sandra N. Ekdawi et al. JOURNAL OF CONTROLLED RELEASE
- Numerical modeling of drug delivery in a dynamic solid tumor microvasculature
- (2015) M. Sefidgar et al. MICROVASCULAR RESEARCH
- Influence of vascular normalization on interstitial flow and delivery of liposomes in tumors
- (2015) Deniz Ozturk et al. PHYSICS IN MEDICINE AND BIOLOGY
- Characterizing EPR-mediated passive drug targeting using contrast-enhanced functional ultrasound imaging
- (2014) Benjamin Theek et al. JOURNAL OF CONTROLLED RELEASE
- The effect of interstitial pressure on therapeutic agent transport: Coupling with the tumor blood and lymphatic vascular systems
- (2014) Min Wu et al. JOURNAL OF THEORETICAL BIOLOGY
- Distribution of the anticancer drugs doxorubicin, mitoxantrone and topotecan in tumors and normal tissues
- (2013) Krupa J. Patel et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Coevolution of Solid Stress and Interstitial Fluid Pressure in Tumors During Progression: Implications for Vascular Collapse
- (2013) Triantafyllos Stylianopoulos et al. CANCER RESEARCH
- Normalizing Tumor Microenvironment to Treat Cancer: Bench to Bedside to Biomarkers
- (2013) Rakesh K. Jain JOURNAL OF CLINICAL ONCOLOGY
- Numerical Modeling of Interstitial Fluid Flow Coupled with Blood Flow through a Remodeled Solid Tumor Microvascular Network
- (2013) M. Soltani et al. PLoS One
- Interstitial Fluid Flow and Drug Delivery in Vascularized Tumors: A Computational Model
- (2013) Michael Welter et al. PLoS One
- Combining two strategies to improve perfusion and drug delivery in solid tumors
- (2013) T. Stylianopoulos et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Vascular Normalization as a Therapeutic Strategy for Malignant and Nonmalignant Disease
- (2013) S. Goel et al. Cold Spring Harbor Perspectives in Medicine
- The effect of interstitial pressure on tumor growth: Coupling with the blood and lymphatic vascular systems
- (2012) Min Wu et al. JOURNAL OF THEORETICAL BIOLOGY
- Normalization of tumour blood vessels improves the delivery of nanomedicines in a size-dependent manner
- (2012) Vikash P. Chauhan et al. Nature Nanotechnology
- A mathematical model for the effect of anti-angiogenic therapy in the treatment of cancer tumours by chemotherapy
- (2012) S.T.R. Pinho et al. NONLINEAR ANALYSIS-REAL WORLD APPLICATIONS
- TGF- blockade improves the distribution and efficacy of therapeutics in breast carcinoma by normalizing the tumor stroma
- (2012) J. Liu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- A new mathematical model for optimizing the combination between antiangiogenic and cytotoxic drugs in oncology
- (2011) Sébastien Benzekry et al. COMPTES RENDUS MATHEMATIQUE
- RIBBON-1: Randomized, Double-Blind, Placebo-Controlled, Phase III Trial of Chemotherapy With or Without Bevacizumab for First-Line Treatment of Human Epidermal Growth Factor Receptor 2–Negative, Locally Recurrent or Metastatic Breast Cancer
- (2011) Nicholas J. Robert et al. JOURNAL OF CLINICAL ONCOLOGY
- Accumulation of sub-100 nm polymeric micelles in poorly permeable tumours depends on size
- (2011) H. Cabral et al. Nature Nanotechnology
- Principles and mechanisms of vessel normalization for cancer and other angiogenic diseases
- (2011) Peter Carmeliet et al. NATURE REVIEWS DRUG DISCOVERY
- A Phase 3 Trial of Bevacizumab in Ovarian Cancer
- (2011) Timothy J. Perren et al. NEW ENGLAND JOURNAL OF MEDICINE
- Delivery of Molecular and Nanoscale Medicine to Tumors: Transport Barriers and Strategies
- (2011) Vikash P. Chauhan et al. Annual Review of Chemical and Biomolecular Engineering
- Longitudinal Investigation of Permeability and Distribution of Macromolecules in Mouse Malignant Transformation Using PET
- (2010) C. B. Rygh et al. CLINICAL CANCER RESEARCH
- Capecitabine, Bevacizumab, and Mitomycin in First-Line Treatment of Metastatic Colorectal Cancer: Results of the Australasian Gastrointestinal Trials Group Randomized Phase III MAX Study
- (2010) Niall C. Tebbutt et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase III Study of Bevacizumab Plus Docetaxel Compared With Placebo Plus Docetaxel for the First-Line Treatment of Human Epidermal Growth Factor Receptor 2–Negative Metastatic Breast Cancer
- (2010) David W. Miles et al. JOURNAL OF CLINICAL ONCOLOGY
- Effect of Pazopanib on Tumor Microenvironment and Liposome Delivery
- (2010) T. D. Tailor et al. MOLECULAR CANCER THERAPEUTICS
- In Vivo Distribution of Polymeric Nanoparticles at the Whole-Body, Tumor, and Cellular Levels
- (2010) Helen Lee et al. PHARMACEUTICAL RESEARCH
- Study of tumor blood perfusion and its variation due to vascular normalization by anti-angiogenic therapy based on 3D angiogenic microvasculature
- (2009) Jie Wu et al. JOURNAL OF BIOMECHANICS
- Phase III Trial of Cisplatin Plus Gemcitabine With Either Placebo or Bevacizumab As First-Line Therapy for Nonsquamous Non–Small-Cell Lung Cancer: AVAiL
- (2009) Martin Reck et al. JOURNAL OF CLINICAL ONCOLOGY
- Independent Review of E2100: A Phase III Trial of Bevacizumab Plus Paclitaxel Versus Paclitaxel in Women With Metastatic Breast Cancer
- (2009) Robert Gray et al. JOURNAL OF CLINICAL ONCOLOGY
- On optimal delivery of combination therapy for tumors
- (2009) Alberto d’Onofrio et al. MATHEMATICAL BIOSCIENCES
- Tumor Vascular Permeability to a Nanoprobe Correlates to Tumor-Specific Expression Levels of Angiogenic Markers
- (2009) Efstathios Karathanasis et al. PLoS One
- Interstitial fluid pressure in tumors: therapeutic barrier and biomarker of angiogenesis
- (2008) Sarah Jane Lunt et al. Future Oncology
- Optimal and suboptimal protocols for a class of mathematical models of tumor anti-angiogenesis
- (2008) Urszula Ledzewicz et al. JOURNAL OF THEORETICAL BIOLOGY
- Combination of antiangiogenesis with chemotherapy for more effective cancer treatment
- (2008) J. Ma et al. MOLECULAR CANCER THERAPEUTICS
- A theoretical study of the response of vascular tumours to different types of chemotherapy
- (2007) Jasmina Panovska et al. MATHEMATICAL AND COMPUTER MODELLING
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now